logo

Cocrystal Pharma, Inc. (COCP)



Trade COCP now with
  Date
  Headline
11/12/2018 8:12:28 AM Cocrystal Q3 Net Loss $1.87 Mln Vs Loss $2.26 Mln Last Year
10/8/2018 8:15:07 AM Cocrystal Pharma Announces Clinical Trial Deal For Investigator-Initiated Phase 2a Study In Hong Kong Of CC-31244
9/20/2018 8:08:40 AM Cocrystal Pharma Completes Patient Enrollment In Phase 2a Study Of CC-31244 For Ultra-Short Treatment Of Hepatitis C
8/9/2018 8:13:58 AM Cocrystal Pharma Q2 Net Loss $1.34 Mln Vs Loss $1.0 Mln Last Year
6/28/2018 7:37:51 AM Cocrystal Pharma Begins Enrollment And Initiates Patient Dosing In Phase 2a Study Evaluating CC-31244
6/11/2018 7:31:10 AM Neovasc Elects Steve Rubin As Chairman Of Board
5/11/2018 8:12:38 AM Cocrystal Pharma Announces Final Results Of Its Tender Offer
5/1/2018 8:36:35 AM Cocrystal Prices Public Offering Of 4.21 Mln Shares Of Its Common Stock
4/3/2018 8:14:07 AM Cocrystal Pharma Gets FDA Clearance To Begin Phase 2a Trial To Evaluate CC-31244 For Hepatitis C Virus
3/22/2018 7:08:17 AM Cocrystal Pharma FY Net Loss $613K Vs Loss Of $74.87 Mln Last Year